May 2021 - Volume 3, Issue 1
Volume 3, Issue 1
Shaw et al. describe a case of high-dose cannabidiol treatment for acute opioid withdrawal in a patient with opioid use disorder during the transition to abstinence maintenance. Boehnke examines national trends in qualifying conditions for medical cannabis. Experts paint a cautionary tale for the medical supply as more states move toward adult-use cannabis and we explore how cannabinoid-based therapy can both hurt and help patients infected with COVID-19.
In this Issue
Grad Student Insights
Original Research
he aim of this study was to evaluate the effect of a repeat-action tablet containing 10 mg THC and 5 mg CBN on sleep quality, sleep duration, and awakenings in participants (medical cannabis users). The effect of the combination tablet was evaluated using objectively measured and self-reported data.
Although CBD products are generally recognized as effective and safe, potential safety concerns exist that may go unaddressed. This study demonstrates that pharmacists, who are one of the most accessible health care professionals, can serve as a valuable resource to patients regarding the safe use of CBD products.
Cannabis in the News
With false claims circulating about the effectiveness of cannabis to treat COVID-19 and studies rapidly pouring out of labs and hospitals, it is challenging to make sense of it all. AJEM spoke with leading cannabis researchers and physicians to reflect on what we’ve learned after a year of COVID-19. In short, it’s complicated. Medical cannabinoid…
Cannabis Policy
The year 2020 brought a tsunami of events that led to a rise in demand and a fall in supply of medical cannabinoid products in the United States. AJEM spoke with officials and physicians from 3 states that were reporting cannabis shortages—Illinois, Maryland, and Florida—about its effect on patients. Additionally, panic-related buying due to the…
Clinical Distillation
Pain researcher discusses findings from his latest study: Boehnke KF, et al. Qualifying conditions of medical cannabis license holders in the United States. Health Aff (Millwood). 2019;38(2):295-302.
A pediatric critical care physician provides commentary on a recent study: Efron D, et al. Does cannabidiol reduce severe behavioural problems in children with intellectual disability? Study protocol for a pilot single-site I/II randomized placebo-controlled trial. BMJ Open. 2020;10(3):e034362.
Practice Spotlight
Editorial
I am, if nothing else, a champion of women and have been so my entire career, including in my current role in the medical cannabis field as well as in my 18 years as a board-certified obstetrician and gynecologist (OB/GYN). Co-founding the female-owned medical cannabis dispensary, Greenhouse Wellness, and developing female-focused medical cannabis products are…
We are entering a time in the cannabis industry when research and accurate reporting of scientific outcomes are becoming increasingly important. The field is facing competition from unlikely sources.
